Morgan Keegan Lowers PT On Emeritus To $24

Morgan Keegan has lowered the price target on Emeritus Corporation ESC from $29 to $24 and maintains its Outperform rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetAnalyst RatingsHealth CareHealth Care FacilitiesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!